로딩 중…
지수 로딩 중…
Prime Medicine, Inc.
PRME· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.81-3.77%
2026-08-03
Financials
Valuation Metrics
Prime Medicine, Inc.'s Market Cap is $508M. At end of 2025 it was $516M. Ranked #2794 of 3,112 in US market (top 90%), #1216 of 1,445 on NASDAQ (top 84%), #225 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 84%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $508M | US#2,794/3,112 Sec#225/269 |
| Revenue | $4M | US#2,944/3,112 Sec#191/269 |
| Net Income | $-198M | US—/3,112 Sec—/269 |
| Total Assets | $295M | US#2,899/3,112 Sec#212/269 |
| Net Assets | $77M | US#2,906/3,112 Sec#235/269 |
| Value | ||
| P/B | 6.62x | US#2,379/3,112 Sec#167/269 |
| P/S | 125.81x | US#2,917/3,112 Sec#184/269 |
| FCF Yield | -31.28% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROA | -67.31% | US#3,018/3,112 Sec#247/269 |
| Op. Margin | -5121.77% | US#2,948/3,112 Sec#189/269 |
| Revenue Growth | -41.13% | US#2,861/3,112 Sec#161/269 |
| Financial Health | ||
| Debt Ratio | 284.26% | US#2,078/3,112 Sec#218/269 |
| Total Debt | $115M | US#2,348/3,112 Sec#112/269 |
| FCF | $-159M | US#2,688/3,112 Sec#193/269 |
| Cash | $64M | US#2,466/3,112 Sec#208/269 |
| Current Ratio | 3.80x | US#611/3,112 Sec#172/269 |
| Performance | ||
| 1Y Return | -30.45% | US#2,856/3,112 Sec#235/269 |
| 1M Return | -27.39% | US#3,045/3,112 Sec#251/269 |
| From 52W High | -59.51% | US#2,934/3,112 Sec#241/269 |
| 1Y MDD | -59.52% | US#2,706/3,112 Sec#212/269 |
| Trading | ||
| Volume | 3,879,221 shares | US#485/3,112 Sec#37/269 |
| Trading Value | $11M | US#2,294/3,112 Sec#182/269 |
| Per Share | ||
| EPS | $-1.35 | US—/3,112 Sec—/269 |
| BPS | $0.81 | US#2,645/3,112 Sec#208/269 |